Sarepta Therapeutics (SRPT) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.65% |
| Dec 31, 2025 | -13.81% |
| Sep 30, 2025 | -22.79% |
| Jun 30, 2025 | -20.81% |
| Mar 31, 2025 | -32.85% |
| Dec 31, 2024 | 5.72% |
| Sep 30, 2024 | -22.87% |
| Jun 30, 2024 | -13.85% |
| Mar 31, 2024 | -10.21% |
| Dec 31, 2023 | 2.93% |
| Sep 30, 2023 | 20.91% |
| Jun 30, 2023 | 15.73% |
| Mar 31, 2023 | 9.36% |
| Dec 31, 2022 | 10.02% |
| Sep 30, 2022 | 10.95% |
| Jun 30, 2022 | 38.84% |
| Mar 31, 2022 | 35.04% |
| Dec 31, 2021 | 76.82% |
| Sep 30, 2021 | 32.26% |
| Jun 30, 2021 | 104.17% |
| Mar 31, 2021 | 60.16% |
| Dec 31, 2020 | 79.65% |
| Sep 30, 2020 | 92.48% |
| Jun 30, 2020 | 88.16% |
| Mar 31, 2020 | 88.34% |
| Dec 31, 2019 | 62.57% |
| Sep 30, 2019 | 69.18% |
| Jun 30, 2019 | 51.07% |
| Mar 31, 2019 | 71.67% |
| Dec 31, 2018 | 7.61% |
| Sep 30, 2018 | -5.18% |
| Jun 30, 2018 | 21.31% |
| Mar 31, 2018 | 27.11% |
| Dec 31, 2017 | 26.16% |
| Sep 30, 2017 | 74.67% |
| Jun 30, 2017 | 47.04% |
| Mar 31, 2017 | 55.14% |
| Dec 31, 2016 | 25.13% |
| Sep 30, 2016 | 53.51% |
| Jun 30, 2016 | -2.46% |
| Mar 31, 2016 | 43.28% |
| Dec 31, 2015 | 19.04% |
| Sep 30, 2015 | 9.19% |
| Jun 30, 2015 | 13.61% |